(E)-6-(4-(cyclohexylamino)butoxy)-2-(4-(dimethylamino)benzylidene)-5-methoxy-2,3-dihydro-1H-inden-1-one

ID: ALA3343717

Chembl Id: CHEMBL3343717

PubChem CID: 118717266

Max Phase: Preclinical

Molecular Formula: C29H38N2O3

Molecular Weight: 462.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OCCCCNC1CCCCC1)C(=O)/C(=C/c1ccc(N(C)C)cc1)C2

Standard InChI:  InChI=1S/C29H38N2O3/c1-31(2)25-13-11-21(12-14-25)17-23-18-22-19-27(33-3)28(20-26(22)29(23)32)34-16-8-7-15-30-24-9-5-4-6-10-24/h11-14,17,19-20,24,30H,4-10,15-16,18H2,1-3H3/b23-17+

Standard InChI Key:  TUCQFSSTZGTFRV-HAVVHWLPSA-N

Alternative Forms

  1. Parent:

    ALA3343717

    ---

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Butyrylcholinesterase (805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.63Molecular Weight (Monoisotopic): 462.2882AlogP: 5.66#Rotatable Bonds: 10
Polar Surface Area: 50.80Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.83CX LogP: 5.70CX LogD: 2.67
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.36Np Likeness Score: -0.30

References

1. Huang L, Miao H, Sun Y, Meng F, Li X..  (2014)  Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.,  87  [PMID:25282266] [10.1016/j.ejmech.2014.09.081]

Source